Containerboard production was down 3.0 percent compared to February 2017 and down 1.1 percent year-to-date. The month-over-month average daily production compared to January 2018 was 3.2 percent lower. The containerboard operating rate was 94.1 percent, or 3.1 percentage points lower than the same month last year. Production for exports was 6.0 percent lower than February 2017 and 8.4 percent lower year-to-date.
http://afandpa.org/media/news/2018/03/16/american-forest-paper-association-releases-february-2018-containerboard-report
Related Posts
ePac Flexible Packaging, founded in 2016 as the world’s first all-digital flexible packaging company, just turned 8 years old in May of this year. So it’s fair to ask: How is ePac doing with its disruptive business model? From 2016 through 2022 ePac consistently grew 50 -100% per year. In 2023 ePac’s growth slowed, but units produced still increased 30% over 2022 as new customer acquisition remained strong. Today, ePac is an international company with ~$200M in sales. In 2023, and still in 2024, the flexible packaging industry came under significant financial pressure caused by a myriad of factors including inflation, higher interest rates, supply chain issues, emergence from COVID 19, and the availability of capital. The industry, in general, saw top line sales decline and underlying costs increase. ePac responded with a reassessment of its strategy, and took several key steps to mitigate what was/is happening industry-wide.
UPM Raflatac will launch a brand new product range for medical device and healthcare industry. New RPMD is a multi-faceted adhesive that is ideal for labeling medical devices. Selection of different face materials with new RPMD adhesive are specially designed for different medical device sub-segments such as sterilization wraps and bags, infusion bags and bottles, drug-device combinations like pens, auto-injectors and inhalers and blood donation labeling. RPMD adhesive combines excellent adhesion with a tight mandrel hold on glass and plastic and is sterilization resistant and migration safe. "In April 2017 the EU Commission formally adopted two new regulations on medical devices and in vitro diagnostic medical devices. One of the main regulatory updates is the implementation of a Unique Device Identification system (UDI) that provides a globally harmonized and consistent approach for the marking and identification of medical devices", comments Markku Pietarinen, Manager, Business Segments & Pharma, Specials EMEIA. "A UDI is a code printed on a label affixed to a device or its packaging, or even directly on the device itself, in both plain text and machine-readable format. All medical devices available in the EU must comply with the new regulations by April 2020, with the deadline for in vitro diagnostic devices falling two years later, in 2022." Click Read More below for additional information.
UPM Raflatac has joined Ellen MacArthur's Circular Economy 100 programme on its journey towards a more sustainable future. As the world's most sustainable labeling company and as part of UPM, the Biofore Company, UPM Raflatac wants to aim higher and make the circular economy a reality in the whole packaging value chain. The Circular Economy 100 (CE 100) is a pre-competitive innovation programme established to enable organisations to develop new opportunities and realise their circular economy ambitions faster. It brings together corporates, governments and cities, academic institutions, emerging innovators and affiliates in a unique multi-stakeholder platform. Specially developed programme elements help members learn, build capacity, network, and collaborate with key organisations around the circular economy. Click Read More below for additional information.